BECTON DICKINSON AND CO (BDX) Stock Price, Quote, News and Overview
NYSE:BDX - New York Stock Exchange, Inc. - US0758871091 - Common Stock - Currency: USD
BDX Quote, Performance and Key Statistics
227.43
-0.5 (-0.22%)
The current stock price of BDX is 227.43 USD. In the past month the price decreased by -4.2%. In the past year, price decreased by -7.42%.
BDX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.63B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B | ||
| STE | STERIS PLC | 24.03 | 21.67B |
Related stock screener links
About BDX
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring solutions and pharmaceutical systems. The firm's BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417 US
CEO: Thomas E. Polen
Employees: 73000
Company Website: https://www.bd.com/
Investor Relations: https://investors.bd.com/
Phone: 12018476800
BECTON DICKINSON AND CO / BDX FAQ
What is the stock price of BECTON DICKINSON AND CO today?
The current stock price of BDX is 227.43 USD. The price decreased by -0.22% in the last trading session.
What is the ticker symbol for BECTON DICKINSON AND CO stock?
The exchange symbol of BECTON DICKINSON AND CO is BDX and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BDX stock listed?
BDX stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for BECTON DICKINSON AND CO stock?
22 analysts have analysed BDX and the average price target is 278.82 USD. This implies a price increase of 22.6% is expected in the next year compared to the current price of 227.43. Check the BECTON DICKINSON AND CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BECTON DICKINSON AND CO worth?
BECTON DICKINSON AND CO (BDX) has a market capitalization of 65.30B USD. This makes BDX a Large Cap stock.
How many employees does BECTON DICKINSON AND CO have?
BECTON DICKINSON AND CO (BDX) currently has 73000 employees.
What are the support and resistance levels for BECTON DICKINSON AND CO (BDX) stock?
BECTON DICKINSON AND CO (BDX) has a support level at 227.24 and a resistance level at 240.63. Check the full technical report for a detailed analysis of BDX support and resistance levels.
Is BECTON DICKINSON AND CO (BDX) expected to grow?
The Revenue of BECTON DICKINSON AND CO (BDX) is expected to grow by 8.96% in the next year. Check the estimates tab for more information on the BDX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BECTON DICKINSON AND CO (BDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BDX, evaluating the profitability, health, valuation and growth aspects
- BECTON DICKINSON AND CO (BDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BECTON DICKINSON AND CO (BDX) Sales and EPS estimates to see what analysts future expectations are.
- BECTON DICKINSON AND CO (BDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BECTON DICKINSON AND CO (BDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BECTON DICKINSON AND CO (BDX) Stock Chart to make your own analysis
- BECTON DICKINSON AND CO (BDX) Latest news and press-releases to stay up to date.
Does BECTON DICKINSON AND CO (BDX) stock pay dividends?
BECTON DICKINSON AND CO (BDX) has a dividend yield of 1.85%. The yearly dividend amount is currently 3.8. Check the full fundamental report for a detailed analysis of BDX dividend history, reliability and sustainability.
When does BECTON DICKINSON AND CO (BDX) report earnings?
BECTON DICKINSON AND CO (BDX) will report earnings on 2025-05-01, before the market open.
What is the Price/Earnings (PE) ratio of BECTON DICKINSON AND CO (BDX)?
The PE ratio for BECTON DICKINSON AND CO (BDX) is 16.35. This is based on the reported non-GAAP earnings per share of 13.91 and the current share price of 227.43 USD. Check the full fundamental report for a full analysis of the valuation metrics for BDX.
What is the Short Interest ratio of BECTON DICKINSON AND CO (BDX) stock?
The outstanding short interest for BECTON DICKINSON AND CO (BDX) is 0.95% of its float. Check the ownership tab for more information on the BDX short interest.
BDX Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to BDX. When comparing the yearly performance of all stocks, BDX is a bad performer in the overall market: 68.74% of all stocks are doing better.
BDX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BDX. BDX scores excellent on profitability, but there are concerns on its financial health.
BDX Financial Highlights
Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 13.91. The EPS increased by 16.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.47% | ||
| ROA | 3.2% | ||
| ROE | 6.94% | ||
| Debt/Equity | 0.69 |
BDX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to BDX. The Buy consensus is the average rating of analysts ratings from 22 analysts.
For the next year, analysts expect an EPS growth of 10.71% and a revenue growth 8.96% for BDX